Contact
Please use this form to send email to PR contact of this press release:
vTv Therapeutics Receives FDA Breakthrough Therapy Designation for TTP399 for the Treatment of Type 1 Diabetes
TO:
Please use this form to send email to PR contact of this press release:
vTv Therapeutics Receives FDA Breakthrough Therapy Designation for TTP399 for the Treatment of Type 1 Diabetes
TO: